Tom Van de Casteele

2.6k total citations · 1 hit paper
45 papers, 1.8k citations indexed

About

Tom Van de Casteele is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Tom Van de Casteele has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 19 papers in Virology and 7 papers in Emergency Medicine. Recurrent topics in Tom Van de Casteele's work include HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (19 papers) and HIV/AIDS Research and Interventions (10 papers). Tom Van de Casteele is often cited by papers focused on HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (19 papers) and HIV/AIDS Research and Interventions (10 papers). Tom Van de Casteele collaborates with scholars based in Belgium, United States and United Kingdom. Tom Van de Casteele's co-authors include Erik Matthysen, Peter Galbusera, Magda Opsomer, Erkki Lathouwers, Frank Adriaensen, Thomas N. Kakuda, Frank Tomaka, Martien J. Kas, Bernhard Voelkl and Holger Schielzeth and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature reviews. Neuroscience and Scientific Reports.

In The Last Decade

Tom Van de Casteele

45 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reproducibility of animal research in light of biological variation

2020 224 citations Bernhard Voelkl, Naomi Altman et al. Nature reviews. Neuroscience profile →

Peers

Countries citing papers authored by Tom Van de Casteele

Since Specialization

Citations

This map shows the geographic impact of Tom Van de Casteele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Van de Casteele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Van de Casteele more than expected).

Fields of papers citing papers by Tom Van de Casteele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Van de Casteele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Van de Casteele. The network helps show where Tom Van de Casteele may publish in the future.

Co-authorship network of co-authors of Tom Van de Casteele

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Van de Casteele. A scholar is included among the top collaborators of Tom Van de Casteele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Van de Casteele. Tom Van de Casteele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Opportunities and challenges with decentralized trials in Neuroscience	Biometrical Journal	Hans Ulrich Burger, Tom Van de Casteele et al.	2
2	The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study	The Journal of Headache and Pain	Christina Deligianni, Casper Emil Christensen et al.	24
3	Comparison of commonly used methods in random effects meta-analysis: application to preclinical data in drug discovery research	SHILAP Revista de lepidopterología	Christel Faes, Tom Van de Casteele et al.	50
4	Reply to ‘It is time for an empirically informed paradigm shift in animal research’	Nature reviews. Neuroscience	Hanno Würbel, Bernhard Voelkl et al.	3
5	Reproducibility of animal research in light of biological variation breakdown →	Nature reviews. Neuroscience	Bernhard Voelkl, Naomi Altman et al.	224
6	Author Correction: Reproducibility of animal research in light of biological variation	Nature reviews. Neuroscience	Bernhard Voelkl, Naomi Altman et al.	3
7	Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-β-induced pathology	Alzheimer s Research & Therapy	Jelle Praet, Nikolay V. Manyakov et al.	76
8	Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer’s disease pathology	Scientific Reports	A. Ahnaou, Diederik Moechars et al.	70
9	Cortical high gamma network oscillations and connectivity: a translational index for antipsychotics to normalize aberrant neurophysiological activity	Translational Psychiatry	A. Ahnaou, Tom Van de Casteele et al.	51
10	Safety and Efficacy of Darunavir/Ritonavir in Treatment-experienced Pediatric Patients	The Pediatric Infectious Disease Journal	Avy Violari, Rosa Bologna et al.	13
11	Efficacy and Safety of Darunavir/Ritonavir at 48 Weeks in Treatment-naïve, HIV-1–infected Adolescents	The Pediatric Infectious Disease Journal	Patricia M. Flynn, Stéphane Blanche et al.	20
12	Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulation	International Journal of Clinical Pharmacology and Therapeutics	Thomas N. Kakuda, Lorant Leopold et al.	6
13	Pharmacokinetics of darunavir in fixed‐dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers	The Journal of Clinical Pharmacology	Thomas N. Kakuda, Magda Opsomer et al.	40
14	Effects of once-daily darunavir/ritonavir versus lopinavir/ritonavir on metabolic parameters in treatment-naive HIV-1-infected patients at week 96: ARTEMIS	International Journal of STD & AIDS	Eduardo Arathoon, Stefan Schneider et al.	14
15	Effect of Baseline Characteristics on the Efficacy and Safety of Once-Daily Darunavir/ Ritonavir in HIV-1–Infected, Treatment-Naïve ARTEMIS Patients at Week 96	HIV Clinical Trials	Jan Fourie, Jason Flamm et al.	9
16	Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients	AIDS	Pedro Cahn, Jan Fourie et al.	75
17	Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model	European Respiratory Journal	Wieslawa Olszewska, Gabriela Ispas et al.	42
18	Family movements before independence influence natal dispersal in a territorial songbird	Oecologia	Erik Matthysen, Thijs van Overveld et al.	27
19	Seasonal and lifetime reproductive consequences of inbreeding in the great tit Parus major	Behavioral Ecology	Tom Van de Casteele	26
20	A comparison of microsatellite‐based pairwise relatedness estimators	Molecular Ecology	Tom Van de Casteele, Peter Galbusera et al.	207

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact